Mission Pharmacal
Highly Engaged Employees
Manufacturing · Texas, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
10999 W Interstate 10 Ste 1000, San Anto...Phone Number
(210) 696-8400Website
www.missionpharmacal.comRevenue
$114.1 MillionIndustry
About Mission Pharmacal
Mission Pharmacal Org Chart
Is Mission Pharmacal your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Mission Pharmacal is spiking on competitors!
Funding: Get notified immidiatlly once Mission Pharmacal has new funding data
Congratulate Masked Content for being promoted to Masked Content at Mission Pharmacal
Product Launch: Get notified when Mission Pharmacal launches new products
Website visits: Recent activity has been detected on your website
Check if Mission Pharmacal has recently received funding, and reach out quickly before it becomes old news!
Click to see if Mission Pharmacal had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Mission Pharmacal recently announced quarterly report
Mission Pharmacal, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Mission Pharmacal
Find more new buyers
Compare Similar Companies to Mission Pharmacal
Compare insights from companies similar to Mission Pharmacal, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Mission Pharmacal is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Mission Pharmacal is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Mission Pharmacal.
Mission Pharmacal financials insights
Gather financial insights about Mission Pharmacal, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$5M
Mission Pharmacal Tech Stack
A closer look at the technologies used by Mission Pharmacal
Most Recent Scoops
Mission Pharmacal News & Media
Otonomy Announces OTIPRIO® Co-Promotion Agreement with Mission Pharmacal for Acute Otitis Externa Indication
SAN DIEGO, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced the signing of a co-promotion agreement with Mission Pharmacal Company (“Mission”), a well-established privately held pharmaceutical company, that provides Mission with an exclusive right to promote OTIPRIO (ciprofloxacin otic suspension) for acute otitis externa (AOE) in pediatrician and primary care physicianAlamo Pharma Services, Inc.’s Peter Marchesini serves as chairperson of featured Patient Impact tract during the eyeforpharma 2018 meeting
Known for providing customized recruiting of sales teams, leading sales training, and other commercial services, Alamo helps pharmaceutical and biotech companies successfully bring products to market. Known for providing customized recruiting of sales teams, leading sales training, and other commercial services, Alamo helps pharmaceutical and biotech companies successfully bring products to market.Mission Pharmacal enters into agreement with MainPointe Pharmaceuticals to purchase and license Mission’s consumer products
Mission will continue manufacturing most products involved in the agreement; it is anticipated that product sales will increase due to MainPointe’s heightened consumer focus.FABRE-KRAMER PARTNERS WITH MISSION PHARMACAL FOR FUTURE COMMERCIAL MANUFACTURE OF NOVEL MECHANISM ANTIDEPRESSANT TRAVIVO™ (GEPIRONE HCL) TABLETS
HOUSTON, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Fabre-Kramer Pharmaceuticals, Inc. (Fabre-Kramer) of Houston, TX, and Mission Pharmacal Company (Mission) of San Antonio, TX, announced today that they have signed agreements providing for Mission to complete the technology transfer to develop and manufacture the registration batches of Fabre-Kramer’s novel antidepressant, Travivo (gepirone HCl) Extended Release Tablets. Data from these batches will be used to support the submission of the NDA Amendment
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mission Pharmacal
Mission Pharmacal Company is a privately held pharmaceutical company that develops, manufactures, and markets pharmaceutical products. The company was founded in 1946 and is headquartered in San Antonio, Texas.... Read More